pharmacopeia

Carbon Disulfide

US-FDASourced from openFDA
GET
/api/v1/drug/carbon-disulfide

Indications

Sourced from openFDA
  • Skin rash with tingling*

Dosage & administration

Sourced from openFDA

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Fall1100%
  2. 2Hypoglycaemia1100%
  3. 3Injury1100%

Literature

View JSON

Recent PubMed references pinned to Carbon Disulfide as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 2 most recently updated of 2 ClinicalTrials.gov registrations naming Carbon Disulfide as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

What is Carbon Disulfide used for?
According to FDA labeling, Carbon Disulfide carries indications including: Skin rash with tingling*. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for carbon-disulfide is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients